Optimising the Development of Antibodies as Treatment for Cancer
作者： Craig P. Carden , Hendrik-Tobias Arkenau , Johann S. de Bono
DOI: 10.1007/978-1-4419-7358-0_19
关键词:
摘要: Antibodies are proteins secreted by vertebrates, which bind to specific molecular moieties [1]. Millions of different antibodies made organisms, and early in development most self-recognising removed from the repertoire. The remaining antibodies, accordingly, recognise non-self molecules, used host eliminate microorganisms, foreign objects, malignant cells. Manufacturing these highly molecules using them for cancer treatment represents a major breakthrough.
springer.com
sci-hub.st 参考文章(142)
A. S. -Y. Lo, Q. Zhu, W. A. Marasco, Intracellular Antibodies (Intrabodies) and Their Therapeutic Potential Therapeutic Antibodies. ,vol. 181, pp. 343- 373 ,(2008) , 10.1007/978-3-540-73259-4_15
ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood. ,vol. 83, pp. 435- 445 ,(1994) , 10.1182/BLOOD.V83.2.435.435
C. M. Lynch, I. S. Grewal, Preclinical Safety Evaluation of Monoclonal Antibodies Therapeutic Antibodies. ,vol. 181, pp. 19- 44 ,(2008) , 10.1007/978-3-540-73259-4_2
Robert O. Dillman, Monoclonal antibody therapy Principles of Cancer Biotherapy. pp. 303- 406 ,(2009) , 10.1007/978-90-481-2289-9_10
E.L. Sievers, F.R. Appelbaum, R.T. Spielberger, S.J. Forman, D. Flowers, F.O. Smith, K. Shannon-Dorcy, M.S. Berger, I.D. Bernstein, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. ,vol. 93, pp. 3678- 3684 ,(1999) , 10.1182/BLOOD.V93.11.3678.411K24_3678_3684
B. M. Bradt, G. R. Mirick, S. J. Denardo, Gerald L Denardo, A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Quarterly Journal of Nuclear Medicine and Molecular Imaging. ,vol. 48, pp. 251- 257 ,(2004)
Victor Ghetie, E Sally Ward, Ellen S Vitetta, None, Pharmacokinetics of Antibodies and Immunotoxins in Mice and Humans Humana Press, Totowa, NJ. pp. 475- 498 ,(2004) , 10.1007/978-1-59259-734-5_29
P Stashenko, L M Nadler, S F Schlossman, R Hardy, Characterization of a human B lymphocyte-specific antigen. Journal of Immunology. ,vol. 125, pp. 1678- 1685 ,(1980)
Howard L. McLeod, William D. Figg, Handbook of Anticancer Pharmacokinetics and Pharmacodynamics ,(2004)
Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber, William Novotny, None, Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nature Reviews Drug Discovery. ,vol. 3, pp. 391- 400 ,(2004) , 10.1038/NRD1381